Company: MLTX
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001821586-25-000011
Chunk: 94

Company: MoonLake Immunotherapeutics
Filing Date: 2025-05-12
Form: 10-Q
Item: Part II, Item 6
Chunk 94
---
 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

MOONLAKE IMMUNOTHERAPEUTICS/s/ Dr. Jorge Santos da SilvaDate:May 12, 2025Name:Dr. Jorge Santos da SilvaTitle:Chief Executive Officer(Principal Executive Officer)/s/ Matthias BodenstedtDate:May 12, 2025Name:Matthias BodenstedtTitle:Chief Financial Officer(Principal Financial and Accounting Officer)

49